is manjaro a glp-1 drug Understanding Mounjaro: Guide for Type 2 Diabetes Patients Compound versions of GLP-1 drugs

Second-generation antipsychotics and dysregulation of glucose metabolism: beyond weight gain

Turan, I., Sayan Ozacmak, H., Ozacmak, V

As frequently recognised co-morbidities with atherosclerotic cardiovascular disease (ASCVD), type 2 diabetes mellitus (T2DM) and overweight/obesity are rapidly becoming pandemics of dysregulated metabolic health

Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas

"We strongly believe from a scientific perspective that the therapeutic approach to obesity through medication is going to be through combination therapy, through drugs that hit different pathways that are involved in energy homeostatis." The company is now pushing ahead trials of several new agents

January 29, 2026: More Early Progress for Ozempic Blindness Lawsuits The Ozempic vision loss MDL is continuing to progress, with multiple case management orders now in place and some of the early procedural work for this litigation getting underway